NCT07703683 Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
| NCT ID | NCT07703683 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| Condition | Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-02-19 |
| Primary Completion | 2056-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-02-19 with a primary completion date of 2056-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population. .
Eligibility Criteria
Inclusion Criteria: * Metabolic or endocrine disease Exclusion Criteria: * Known myopathy * Systemic steroid use (\> 1 mg/kg hydrocortisone) or exogenous Cushing's syndrome * Psychological, family, sociological or geographical conditions that could potentially limit compliance with the study protocol * History of cancer within the five years prior to the study or Cushing's syndrome due to ACTH-secreting tumor
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07703683 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07703683 currently recruiting?
Yes, NCT07703683 is actively recruiting participants. Contact the research team at laura.orioli@saintluc.uclouvain.be for enrollment information.
Where is the NCT07703683 trial being conducted?
This trial is being conducted at Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, Belgium.
Who is sponsoring the NCT07703683 clinical trial?
NCT07703683 is sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.